Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Can J Physiol Pharmacol ; 88(12): 1157-65, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21164562

ABSTRACT

The amount of triacylglycerol (TAG) that accumulates in adipose tissue depends on 2 opposing processes: lipogenesis and lipolysis. We have previously shown that the weight and lipid content of epididymal (EPI) adipose tissue increases in growing rats fed a low-protein, high-carbohydrate (LPHC) diet for 15 days. The aim of this work was to study the pathways involved in lipogenesis and lipolysis, which ultimately regulate lipid accumulation in the tissue. De novo fatty acid synthesis was evaluated in vivo and was similar for rats fed an LPHC diet or a control diet; however, the LPHC-fed rats had decreased lipoprotein lipase activity in the EPI adipose tissue, which suggests that there was a decreased uptake of fatty acids from the circulating lipoproteins. The LPHC diet did not affect synthesis of glycerol-3-phosphate (G3P) via glycolysis or glyceroneogenesis. Glycerokinase activity - i.e., the phosphorylation of glycerol from the hydrolysis of endogenous TAG to form G3P - was also not affected in LPHC-fed rats. In contrast, adipocytes from LPHC animals had a reduced lipolytic response when stimulated by norepinephrine, even though the basal adipocyte lipolytic rate was similar for both of the groups. Thus, the results suggest that the reduction of lipolytic activity stimulated by norepinephrine seems essential for the TAG increase observed in the EPI adipose tissue of LPHC animals, probably by impairment of the process of activation of lipolysis by norepinephrine.


Subject(s)
Adipose Tissue/metabolism , Dietary Carbohydrates/administration & dosage , Dietary Proteins/administration & dosage , Fatty Acids/metabolism , Glycerophosphates/metabolism , Lipid Metabolism , Adipocytes/metabolism , Adiposity , Animals , Diet , Diet, Protein-Restricted , Dietary Carbohydrates/metabolism , Dietary Proteins/metabolism , Eating , Glycerol Kinase/metabolism , Glycolysis , Lipogenesis , Lipolysis , Lipoprotein Lipase/metabolism , Lipoproteins/metabolism , Male , Norepinephrine/metabolism , Rats , Rats, Wistar , Triglycerides/metabolism
2.
J Ethnopharmacol ; 115(3): 515-9, 2008 Feb 12.
Article in English | MEDLINE | ID: mdl-18063496

ABSTRACT

In the present paper the anti-diabetic effects of stem-bark extract (ethanol 70%) of Vatairea macrocarpa, a traditional diabetes mellitus treatment widely used in Brazil, are reported. The extract was administered orally at a dose of 250 or 500 mg/kg, for 22 days, to normal and streptozotocin-diabetic rats. In extract treated (500 mg/kg) diabetic rats serum and urinary glucose, urinary urea, food and fluid intake were decreased, while body weight gain was increased, all of which indicate an improvement in diabetic state (p<0.05). No effects of the extract were observed in non-diabetic rats. In extract treated (500 mg/kg) diabetic group HOMA-R (homeostasis model for assessment of insulin resistance) was lower at the end of 22 days, as compared to diabetic non treated control group. Insulin was the reference substance used in the experiments. In an oral glucose tolerance test, the time to reach maximal glycemia was greater in diabetic 500 mg/kg treated group than in control group. These anti-diabetic effects could be related to an improved insulin resistance, although a possible effect on pancreatic B-cell function cannot be excluded. Thus, our data of sub-chronic experiments suggest that long-term use of V. macrocarpa stem-bark extract may be helpful in treating diabetic conditions.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Fabaceae/chemistry , Plant Extracts/pharmacology , Administration, Oral , Animals , Blood Glucose/drug effects , Brazil , Disease Models, Animal , Dose-Response Relationship, Drug , Glucose Tolerance Test , Insulin Resistance , Male , Medicine, Traditional , Plant Extracts/administration & dosage , Rats , Rats, Wistar , Streptozocin , Time Factors , Urea/urine , Weight Gain/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...